GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)-AN INTERIM ANALYSIS

SJ Schuster, MR Bishop, C Tam, EK Waller, P Borchmann, J Mcguirk, U Jäger, S Jaglowski, C Andreadis, J Westin, I Fleury, V Bachanova, SR Foley, PJ Ho, S Mielke, H Holte, O Anak, L Pacaud, R Awasthi, F Tai Show all